HAMPTON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Celldex announced today the presentation of histology data from the Company’s ongoing Phase 2 study of barzolvolimab in eosinophilic esophagitis (EoE).
CINCINNATI, OHIO, UNITED STATES, November 4, 2022 /EINPresswire.com/ -- – General Data Healthcare, a division of General Data Company, Inc. and a global leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback